Higher temperatures may decrease antidepressant pollution in waterways
A new study led by Monash University biologists has found that higher temperatures may reduce effects of antidepressant pollution on wildlife.
A new study led by Monash University biologists has found that higher temperatures may reduce effects of antidepressant pollution on wildlife.
Ecology
Feb 9, 2022
0
50
The Monash scientists who found that pharmaceutical pollutants in waterways altered reproductive behavior, anxiety levels, activity and antipredator responses of fish have now discovered for the first time that such toxicity ...
Ecology
Nov 13, 2019
0
245
Antidepressants are making their way into our lakes and rivers—and they're making freshwater fish less fazed by predators.
Ecology
Nov 30, 2017
0
41
Mercyhurst College's research of contaminants in the recreational waters at Presque Isle State Park got a $250,000 boost from the U.S. Environmental Protection Agency, it was announced today.
Environment
Nov 18, 2010
0
0
The popular anti-depressant Prozac can inhibit sexual activity in fish if it seeps into waterways, according to a Canadian study published Tuesday.
Ecology
Sep 21, 2010
0
0
(PhysOrg.com) -- Rising levels of antidepressants in coastal waters could change sea-life behaviour and potentially damage the food-chain, according to a new study.
Ecology
Jul 13, 2010
1
0
Fluoxetine (also known by the tradenames Prozac, Sarafem, Fontex) is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is manufactured and marketed by Eli Lilly and Company. In combination with olanzapine it is known as Symbyax.
Fluoxetine is approved for the treatment of major depression (including pediatric depression), obsessive-compulsive disorder (in both adult and pediatric populations), bulimia nervosa, panic disorder and premenstrual dysphoric disorder.
Despite the availability of newer agents, fluoxetine remains extremely popular. In 2010, over 24.4 million prescriptions for generic formulations of fluoxetine were filled in the United States alone, making it the third most prescribed antidepressant after sertraline (SSRI; became generic in 2006) and citalopram (SSRI; became generic in 2003) in that country.
This text uses material from Wikipedia, licensed under CC BY-SA